AU2022900644A0 - Compositions and Methods for Treating Non-Neurological Disorders with Combination Products - Google Patents

Compositions and Methods for Treating Non-Neurological Disorders with Combination Products

Info

Publication number
AU2022900644A0
AU2022900644A0 AU2022900644A AU2022900644A AU2022900644A0 AU 2022900644 A0 AU2022900644 A0 AU 2022900644A0 AU 2022900644 A AU2022900644 A AU 2022900644A AU 2022900644 A AU2022900644 A AU 2022900644A AU 2022900644 A0 AU2022900644 A0 AU 2022900644A0
Authority
AU
Australia
Prior art keywords
compositions
methods
neurological disorders
treating non
combination products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022900644A
Inventor
Patrick Calabria
Esra Isikgel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dolce Cann Global Pty Ltd
Original Assignee
Dolce Cann Global Pty Ltd
Filing date
Publication date
Application filed by Dolce Cann Global Pty Ltd filed Critical Dolce Cann Global Pty Ltd
Publication of AU2022900644A0 publication Critical patent/AU2022900644A0/en
Priority to PCT/AU2023/050008 priority Critical patent/WO2023130161A1/en
Pending legal-status Critical Current

Links

AU2022900644A 2022-01-10 2022-03-16 Compositions and Methods for Treating Non-Neurological Disorders with Combination Products Pending AU2022900644A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2023/050008 WO2023130161A1 (en) 2022-01-10 2023-01-10 Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda) along with an additional active agent

Publications (1)

Publication Number Publication Date
AU2022900644A0 true AU2022900644A0 (en) 2022-03-31

Family

ID=

Similar Documents

Publication Publication Date Title
EP4136254A4 (en) Ace2-targeted compositions and methods for treating covid-19
EP3934615A4 (en) Compositions and methods for treating acne
EP3999110A4 (en) Compositions and methods for treating autoimmune disorders
EP4096439A4 (en) Compositions and methods for treating aging-related disorders
EP3917620A4 (en) Compositions and methods for treating neurocognitive disorders
EP3973047A4 (en) Methods and compositions for treating liver disorders
EP3917622A4 (en) Compositions and methods for treating anxiety-related disorders
EP3931336A4 (en) Compositions and methods for treating laminopathies
EP4096675A4 (en) Compositions and methods for treating long covid
EP3979985A4 (en) Compositions and methods for treating central nervous system disorders
IL311854A (en) Compositions and methods for treating neurological disorders with combination products
EP4175572A4 (en) Methods and compositions for treating polycystic ovary syndrome
EP3996712A4 (en) Compositions and methods for treating dementia with lewy bodies
EP3917623A4 (en) Compositions and methods for treating neurocognitive disorders
EP4117528A4 (en) Neurotoxin compositions for use in treating cardiovascular disorders
AU2022900644A0 (en) Compositions and Methods for Treating Non-Neurological Disorders with Combination Products
AU2022900042A0 (en) Compositions and Methods for Treating Non-Neurological Disorders with Combination Products
EP4136103A4 (en) Compositions and methods for treating neuropsychiatric disorders
AU2022900643A0 (en) Compositions and Methods for Treating Non-Neurological Disorders
AU2022900041A0 (en) Compositions and Methods for Treating Non-Neurological Disorders
EP4076429A4 (en) Compositions and methods for treating neuromuscular disorders
EP4232017A4 (en) Compositions and methods for treating neuronal disorders with cannabinoids
AU2022901714A0 (en) Compositions and methods for treating neurological disorders with combination products
AU2022900642A0 (en) Compositions and methods for treating neurological disorders with combination products
EP4175978A4 (en) Compositions and methods for treating crp-mediated diseases